12:00 AM
 | 
Aug 02, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Rotarix regulatory update

The CHMP finalized its review of GlaxoSmithKline's Rotarix and reconfirmed that the rotavirus vaccine is safe and DNA from porcine circovirus type-1 (PCV-1) does not...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >